Filter
617
Filtered Results: 617
Text search:
molecular
markers
Featured
Recommendations
79
New Publications
127
Language
Document type
No document type
272
Guidelines
129
Studies & Reports
125
Manuals
43
Strategic & Response Plan
24
Training Material
10
Fact sheets
10
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
51
Global
27
Latin America and the Carribbean
16
Kenya
15
Tanzania
14
Western and Central Europe
12
Africa
11
Ethiopia
10
South Africa
9
Nigeria
8
Eastern Europe
8
South–East Asia Region
7
Sierra Leone
5
Zimbabwe
5
Philippines
5
Uganda
5
Ukraine
4
Malawi
4
Asia
4
West and Central Africa
4
Western Pacific Region
4
East and Southern Africa
4
Indonesia
4
Nepal
3
Cameroon
3
Congo, Democratic Republic of
3
North America
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Ghana
2
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
Bangladesh
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Namibia
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
104
Public Health
42
Pharmacy & Technologies
26
Key Resources
17
Women & Child Health
15
Capacity Building
4
Toolboxes
TB
79
AMR
63
COVID-19
60
HIV
39
Rapid Response
35
NTDs
34
Mental Health
33
Planetary Health
23
NCDs
17
Ebola & Marburg
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Global Health Education
6
Zika
5
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
Social Ethics
1
Malaria
1
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
29 September 2021
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
Mission report April 2016
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
